114 related articles for article (PubMed ID: 37578081)
1. A novel model incorporating chromatin regulatory factors for risk stratification, prognosis prediction, and characterization of the microenvironment in Wilms tumor.
Zhao X; Chu X; Song L; Tang W
J Gene Med; 2024 Jan; 26(1):e3574. PubMed ID: 37578081
[TBL] [Abstract][Full Text] [Related]
2. Identification of molecular subtypes based on chromatin regulator and tumor microenvironment infiltration characterization in papillary renal cell carcinoma.
Tang Q; Pan D; Xu C; Chen L
J Cancer Res Clin Oncol; 2023 Jan; 149(1):231-245. PubMed ID: 36404389
[TBL] [Abstract][Full Text] [Related]
3. Role of CCT4/ErbB signaling in nephroblastoma: Implications for a biomarker of Wilms tumor.
Wang H; Zhang L; Liu B; Su J; Ni X
Medicine (Baltimore); 2023 Apr; 102(15):e33219. PubMed ID: 37058032
[TBL] [Abstract][Full Text] [Related]
4. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
[TBL] [Abstract][Full Text] [Related]
5. A novel prognosis prediction of esophageal cancer based on chromatin regulator-related lncRNA.
Wang Y; Shi Z; Sun X; Liu J
Medicine (Baltimore); 2023 Jul; 102(28):e34281. PubMed ID: 37443468
[TBL] [Abstract][Full Text] [Related]
6. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
7. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
8. A novel risk score model based on fourteen chromatin regulators-based genes for predicting overall survival of patients with lower-grade gliomas.
Zhang Y; Yu B; Tian Y; Ren P; Lyu B; Fu L; Chen H; Li J; Gong S
Front Genet; 2022; 13():957059. PubMed ID: 36246611
[No Abstract] [Full Text] [Related]
9. RNA-Sequencing, Connectivity Mapping, and Molecular Docking to Investigate Ligand-Protein Binding for Potential Drug Candidates for the Treatment of Wilms Tumor.
Luo JY; Yan SB; Chen G; Chen P; Liang SW; Xu QQ; Gu JH; Huang ZG; Qin LT; Lu HP; Mo WJ; Luo YG; Chen JB
Med Sci Monit; 2020 Mar; 26():e920725. PubMed ID: 32214060
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms' Tumor.
Zheng H; Li BH; Liu C; Jia L; Liu FT
Biomed Res Int; 2020; 2020():4951692. PubMed ID: 32149111
[TBL] [Abstract][Full Text] [Related]
11. Identification of a five-mRNA signature as a novel potential prognostic biomarker in pediatric Wilms tumor.
Lin XD; Wu YP; Chen SH; Sun XL; Ke ZB; Chen DN; Li XD; Lin YZ; Wei Y; Zheng QS; Xu N; Xue XY
Mol Genet Genomic Med; 2020 Jan; 8(1):e1032. PubMed ID: 31701684
[TBL] [Abstract][Full Text] [Related]
12. SOX21-AS1 is associated with clinical stage and regulates cell proliferation in nephroblastoma.
Zhang J; Hou T; Qi X; Wang J; Sun X
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992391
[TBL] [Abstract][Full Text] [Related]
13. CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor.
Xiang B; Chen ML; Gao ZQ; Mi T; Shi QL; Dong JJ; Tian XM; Liu F; Wei GH
BMC Med Genomics; 2023 Aug; 16(1):189. PubMed ID: 37592341
[TBL] [Abstract][Full Text] [Related]
14. A Novel Inflammation-Related Gene Signature for Overall Survival Prediction and Comprehensive Analysis in Pediatric Patients with Wilms Tumor.
Zhang J; Lai Y; Zhu L; Lu Z; Hu C; Zhou H; Lu Z; Tang Z; He Z; Tang F
Dis Markers; 2022; 2022():2651105. PubMed ID: 35578692
[TBL] [Abstract][Full Text] [Related]
15. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a prognostic model based on a single-cell RNA-seq in Wilms tumor in children.
He TQ; Zhao YW; Ning F; Liu Y; Tu L; He J
J Investig Med; 2023 Mar; 71(3):173-182. PubMed ID: 36718830
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of chromatin regulator-related signatures as a novel prognostic model for low-grade gliomas using translational bioinformatics.
Wang B; Feng Y; Li Z; Zhou F; Luo J; Yang B; Long S; Li X; Liu Z; Li X; Chen J; Wang L; Wei W
Life Sci; 2024 Jan; 336():122312. PubMed ID: 38042284
[TBL] [Abstract][Full Text] [Related]
18. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
[TBL] [Abstract][Full Text] [Related]
19. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
20. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
